BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 9, 2003
View Archived Issues
GSK develops new glucocorticoid receptor agonists
Read More
New beta3-adrenoceptor agonists identified by Sanofi-Synthelabo team
Read More
Gruenenthal patents new NOS inhibitors with utility in migraine therapy
Read More
Three related series of adenosine A2A antagonists claimed by Schering-Plough
Read More
Sepracor patent covers novel tramadol analogues for pain and other uses
Read More
Novel monoamine uptake modulators prepared and tested by Sepracor researchers
Read More
Antitumor Cdc25 phosphatase inhibitors designed at Maxia
Read More
Short- and long-term efficacy reported for cinacalcet in secondary hyperparathyroidism
Read More
Improved iron balance found for deferasirox in iron-loaded patients with beta-thalassemia
Read More
Suramin inhibits liver cell apoptosis in vitro and in vivo
Read More
Aramchol induces ABCA1-dependent efflux of cholesterol and phospholipids in vitro
Read More
Broad crosslicensing agreement between Ipsen and Teijin
Read More
Xoma regains rights to Neuprex
Read More
Amgen/Wyeth seek approval for fifth indication for anti-TNF therapy
Read More
FDA advisory committee schedules Ranexa NDA for review
Read More
PI-88 achieves primary efficacy endpoint in multiple myeloma trial
Read More
Japanese launch announced for OxyContin
Read More
Puricase advances through the clinical pipeline for refractory gout
Read More
Angeliq cleared for pan-European launch
Read More
AVI BioPharma proceeds towards clinical testing of West Nile virus antisense drug
Read More
Major global study examines second-generation HCV combination therapy in nonresponders
Read More
First preclinical data supporting AP-23464 as an alternative to Gleevec
Read More
Potent inhibitor of in vitro HCV replication presented at EASL meeting
Read More